Bruce Gerhardt - Jul 16, 2021 Form 4 Insider Report for BIOCEPT INC (BIOC)

Role
Director
Signature
/s/ Michael W. Nall, Attorney-in-fact
Stock symbol
BIOC
Transactions as of
Jul 16, 2021
Transactions value $
$0
Form type
4
Date filed
7/20/2021, 04:46 PM
Next filing
Sep 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOC Employee Stock Option (right to buy) Award $0 +10K $0.00 10K Jul 16, 2021 Common Stock 10K $3.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall be 100% vested and exercisable on July 16, 2022.